Brenda Mishell Ruiz Borja

Brenda Mishell Ruiz Borja

Auto-generated profile, based on publicly available information

Brenda Mishell Ruiz Borja

Universidad de las Américas

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
MGMartin Gomez-Lujan
Martin Gomez-Lujan
GVGerardo Amaya Villagran
Gerardo Amaya Villagran
BBBrenda Mishell Ruiz Borja
Brenda Mishell Ruiz Borja
AVAnthony Jesús Pastrana Villares
Anthony Jesús Pastrana Villares
VAVera Sanchez Brandon Abel
Vera Sanchez Brandon Abel
CLCristobal Washigton Franco Lucas
Cristobal Washigton Franco Lucas
Cardiometabolic diseases currently represent one of the leading causes of morbidity and mortality worldwide. The growing coexistence of obesity, insulin resistance, type 2 diabetes mellitus, hypertension, dyslipidemia, chronic kidney disease, and cardiovascular disease has contributed to the development of the cardiometabolic continuum concept, which describes the progressive interaction between metabolic and cardiovascular dysfunction. The objective of this review was to analyze the current scientific evidence regarding the integration of cardiovascular and endocrine risk factors within contemporary clinical practice, emphasizing pathophysiological mechanisms, epidemiological impact, preventive strategies, and therapeutic approaches associated with cardiometabolic disease. A narrative and analytical literature review was conducted using scientific databases including PubMed, Scopus, ScienceDirect, and major international medical journals. Priority was given to clinical guidelines, randomized clinical trials, systematic reviews, and epidemiological studies published in recent years. The analysis focused on the relationship between obesity, inflammation, endothelial dysfunction, insulin resistance, atherosclerosis, cardiovascular disease, and chronic kidney disease, with particular attention to Latin American populations from Mexico, Colombia, and Ecuador. The reviewed evidence demonstrated that cardiometabolic diseases evolve through interconnected inflammatory, metabolic, vascular, and renal mechanisms rather than isolated pathological processes. Obesity and insulin resistance were identified as major contributors to systemic inflammation, endothelial injury, oxidative stress, and accelerated cardiovascular deterioration. Major clinical trials evaluating sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists showed significant reductions in cardiovascular events, heart failure hospitalization, renal disease progression, and cardiometabolic complications.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
YTYurany Duarte Torres
Yurany Duarte Torres
GVGerardo Amaya Villagran
Gerardo Amaya Villagran
BBBrenda Mishell Ruiz Borja
Brenda Mishell Ruiz Borja
MHMoshé Daniel Morales Hernández
Moshé Daniel Morales Hernández
CLCristobal Washigton Franco Lucas
Cristobal Washigton Franco Lucas
NANemesis Alhelí Pineda Alfaro
Nemesis Alhelí Pineda Alfaro
Metabolic syndrome is currently recognized as a major multisystem disorder associated with significant cardiovascular, renal, endocrine, and inflammatory complications. The present review aimed to analyze the pathophysiological mechanisms, epidemiological characteristics, cardiovascular and renal outcomes, and current therapeutic perspectives associated with metabolic syndrome through an integrative analysis of recent scientific literature. A narrative and integrative review methodology based on the Scientific Method and a Process-Based Approach was employed using peer-reviewed publications indexed in PubMed, Scopus, and internationally recognized medical journals. The analyzed evidence demonstrated that insulin resistance, visceral obesity, chronic low-grade inflammation, oxidative stress, endothelial dysfunction, and neurohormonal activation constitute the principal mechanisms underlying multisystem deterioration in metabolic syndrome. Cardiovascular complications including coronary artery disease, heart failure, hypertension, and cerebrovascular disease were strongly associated with metabolic dysfunction. Additionally, chronic kidney disease progression appeared closely linked to glomerular hyperfiltration, fibrosis, inflammatory injury, and endothelial impairment. Epidemiological findings from Mexico, Colombia, and Ecuador revealed increasing prevalence patterns associated with obesity, sedentary lifestyles, nutritional transition, and socioeconomic disparities. The review also identified the importance of multidisciplinary therapeutic strategies involving lifestyle modification, cardiovascular risk reduction, glycemic control, renal protection, and emerging pharmacological therapies such as GLP-1 receptor agonists and SGLT2 inhibitors. Overall, metabolic syndrome should be understood as a systemic cardiometabolic disorder requiring comprehensive clinical management, preventive medicine strategies, and continued scientific investigation to reduce long-term morbidity and mortality.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
SASantiago Alberto Avila Ak
Santiago Alberto Avila Ak
JGJeanina de Los Angeles Montero Galban
Jeanina de Los Angeles Montero Galban
FYFabián Patricio Miranda Yáñez
Fabián Patricio Miranda Yáñez
DPDidier Leonidas Díaz Parra
Didier Leonidas Díaz Parra
ELEdunice Beatriz Mora López
Edunice Beatriz Mora López
BBBrenda Mishell Ruiz Borja
Brenda Mishell Ruiz Borja
Arrhythmias and sudden cardiac death represent major challenges in sports cardiology because they may occur in apparently healthy athletes and may be related to structural heart disease, inherited channelopathies, coronary abnormalities, myocarditis, or other arrhythmogenic substrates. This study analyzed the principal factors associated with sudden cardiac death in athletes, with emphasis on cardiovascular preparticipation evaluation, electrocardiographic interpretation, characterization of ventricular arrhythmias, and perioperative cardiovascular management. An integrative review and analytical synthesis of clinical guidelines, consensus statements, epidemiological studies, systematic reviews, and relevant observational investigations was performed using evidence from recognized scientific databases and international cardiovascular societies. The findings demonstrated that sudden cardiac death is uncommon overall but is heterogeneously distributed, with higher incidence reported in specific groups such as male athletes, Black athletes, and Division I male basketball players. Hypertrophic cardiomyopathy, congenital coronary artery anomalies, myocarditis, arrhythmogenic cardiomyopathy, and inherited electrical disorders were identified among the principal underlying conditions. Athlete-specific electrocardiographic criteria reduced abnormal classifications while preserving the detection of clinically significant cardiovascular disease. The analysis of ventricular ectopy showed that morphology, complexity, exercise response, symptoms, and the presence of structural abnormalities are more clinically informative than arrhythmic burden alone. In the perioperative setting, high functional capacity does not eliminate cardiovascular risk, particularly in athletes with known or suspected arrhythmogenic substrates. Electrolyte disturbances, autonomic fluctuations, anesthetic agents, hypoxemia, hemodynamic changes, and surgical stress may facilitate perioperative rhythm disturbances. The evidence supports an integrated and individualized strategy combining preparticipation screening, targeted diagnostic testing, arrhythmic risk stratification, shared decision-making, and perioperative planning. This approach may improve the identification of high-risk athletes while avoiding unnecessary restrictions and promoting safer participation in sport and surgical care.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
ESEsteban Marrufo Sumano
Esteban Marrufo Sumano
FCFabio Camilo Jaramillo Contreras
Fabio Camilo Jaramillo Contreras
RMRodolfo Garcia Montemayor
Rodolfo Garcia Montemayor
AGAndrés Gabriel Poblano Gallo
Andrés Gabriel Poblano Gallo
KVKenya Fernanda Reséndez Vázquez
Kenya Fernanda Reséndez Vázquez
BBBrenda Mishell Ruiz Borja
Brenda Mishell Ruiz Borja
Cancer is currently recognized as a systemic and multifactorial disease involving complex interactions between metabolism, immunity, endocrinology, inflammation, and the tumor microenvironment. The objective of this review was to analyze the metabolic and immune interactions involved in tumor progression from an integrative systemic perspective. A narrative review methodology was employed using scientific literature indexed in PubMed, Scopus, Web of Science, and ScienceDirect between 2020 and 2025. The analyzed evidence demonstrated that tumor progression depends not only on genetic alterations but also on metabolic reprogramming, chronic inflammatory signaling, endocrine dysfunction, immune suppression, and adaptive modifications within the tumor microenvironment. Malignant cells exhibit metabolic flexibility characterized by increased glycolysis, glutamine dependency, altered lipid metabolism, and mitochondrial adaptations that promote survival under hypoxic and nutrient-deprived conditions. Simultaneously, metabolic competition and accumulation of immunosuppressive metabolites impair cytotoxic immune responses and favor immune evasion. Obesity, insulin resistance, hyperinsulinemia, adipokine imbalance, and chronic low-grade inflammation were identified as important systemic contributors to carcinogenesis and tumor dissemination. The review additionally highlighted the relevance of cancer-associated cachexia, chronic inflammation, and therapeutic resistance as systemic manifestations of malignant disease. Current evidence supports the development of integrated therapeutic strategies combining metabolic modulation, immunotherapy, endocrine intervention, and anti-inflammatory approaches. Overall, this review reinforces the concept that cancer progression results from continuous communication between malignant cells and host physiology, emphasizing the importance of multidisciplinary and systemic perspectives in contemporary oncology.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
MBMayra Isabel Moreno Bautista
Mayra Isabel Moreno Bautista
GVGerardo Amaya Villagran
Gerardo Amaya Villagran
BBBrenda Mishell Ruiz Borja
Brenda Mishell Ruiz Borja
JBJose Leonardo Barrera-Ariza
Jose Leonardo Barrera-Ariza
MCMelissa Esmeralda García Cienfuegos
Melissa Esmeralda García Cienfuegos
ARAndré Ayala Rodríguez
André Ayala Rodríguez
Skin manifestations frequently represent visible indicators of systemic disease and may provide important diagnostic clues during clinical evaluation. The objective of this review was to analyze the diagnostic value of dermatological manifestations associated with systemic disorders within the fields of internal medicine and endocrinology. A narrative review methodology based on the scientific method was utilized through the analysis of peer-reviewed literature indexed in PubMed, Scopus, ScienceDirect, and related biomedical databases. The review included studies focused on endocrine, metabolic, autoimmune, renal, hepatic, infectious, vascular, inflammatory, and neoplastic diseases associated with cutaneous findings. The analyzed evidence demonstrated that endocrine-metabolic disorders represented the most frequent group associated with dermatological manifestations, particularly diabetes mellitus, obesity, metabolic syndrome, thyroid dysfunction, and hyperandrogenic states. Common findings included acanthosis nigricans, xerosis, pigmentation changes, inflammatory rashes, vascular lesions, ulcers, and paraneoplastic dermatoses. Autoimmune diseases such as systemic lupus erythematosus and dermatomyositis also exhibited characteristic cutaneous patterns strongly associated with systemic inflammatory activity. Renal and hepatic diseases frequently presented with xerosis, chronic pruritus, jaundice, and vascular skin lesions, while paraneoplastic dermatoses demonstrated considerable relevance as potential indicators of occult malignancy. The review additionally highlighted the educational and interdisciplinary importance of dermatological examination in medical practice. Recognition of skin findings may improve diagnostic suspicion, facilitate earlier intervention, strengthen interdisciplinary collaboration, and support comprehensive patient-centered care. The findings reinforce the concept that the skin functions as a clinically meaningful reflection of systemic disease and should be considered an essential component of physical examination within internal medicine and endocrinology.

6 January 2026 in Ibero-American Journal of Health Science Research
Verified
Journal Article
Open access
BEBryan Santiago Constante Enríquez
Bryan Santiago Constante Enríquez
JQJennifer Viviana Sánchez Quito
Jennifer Viviana Sánchez Quito
JMJennifer Monserrath Guarnizo Mejía
Jennifer Monserrath Guarnizo Mejía
LDLeslie Nicole Flores Díaz
Leslie Nicole Flores Díaz
BBBrenda Mishell Ruiz Borja
Brenda Mishell Ruiz Borja
BVBoris Joel Sinchiguano Velasco
Boris Joel Sinchiguano Velasco
Los trastornos de personalidad representan una categoría compleja y heterogénea de condiciones psicológicas que afectan significativamente la vida emocional, social y funcional de quienes los padecen. En las últimas décadas, los avances en el diagnóstico y tratamiento han permitido una comprensión más profunda de estas alteraciones, destacando la importancia de enfoques integrales y personalizados. La inclusión de criterios más claros en manuales diagnósticos como el DSM-5 y el CIE-11 ha facilitado una identificación más precisa de los distintos trastornos, mientras que herramientas como la evaluación dimensional han complementado las clasificaciones tradicionales. En cuanto al tratamiento, las terapias basadas en evidencia, como la terapia dialéctico-conductual (TDC) y la terapia centrada en esquemas, han mostrado eficacia en el manejo de trastornos como el límite de la personalidad. Asimismo, los avances en farmacoterapia han contribuido a abordar síntomas específicos, aunque su uso sigue siendo complementario a la intervención psicoterapéutica. Este artículo revisa críticamente los progresos recientes en esta área, subrayando la necesidad de un enfoque multidisciplinario que combine investigación, práctica clínica y apoyo psicosocial. Finalmente, se plantean desafíos actuales y futuras direcciones para optimizar la atención a pacientes con trastornos de personalidad, promoviendo su bienestar y funcionalidad a largo plazo.